What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Discover which credit card offers the best cash back for diverse spending. Make informed choices to maximize your rewards!
27,144 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
A major share sale spooked investors and pushed Brightstar Lottery stock down. This guide breaks down what happened, ...
Alphatec (ATEC) is navigating a shifting spine device market. This guide breaks down expected 2025 earnings, key driv...
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...
QuantumScape faces a volatile path from lab breakthroughs to mass production. This guide breaks down what the stock d...
A choppy week toppled many growth names, but poet technologies stock sliding captured particular attention. Here’s wh...
In 2026, unicorns flush with cash face a new bottleneck: cap table gridlock. Despite record funding, ownership comple...
As AI hype cools and traditional earnings prove steadier, the market posture may be sending subtle signals. This arti...
Red Cat Holdings posted a record Q4 revenue of $26.2 million and full-year $40.7 million, but margins stayed thin and...
Cerebras burst onto the public market with a splashy IPO, but a strong first day doesn’t guarantee long-term gains. T...
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...
In a move seen across aging portfolios, a 62-year-old couple bought $480,000 policy to substitute for taxable bonds, ...